{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-001693","form_type":"8-K","ticker":"QURE","cik":"0001590560","company_name":"uniQure N.V.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.097028+00:00","generated_at":"2026-05-26T01:49:40.364241+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"uniQure secures FDA Accelerated Approval pathway for AMT-130; 2024 net loss $239.6M","bullets":["FDA agreed data from Phase I/II AMT-130 studies vs external control may support BLA; cUHDRS as intermediate endpoint, NfL as supportive.","Cash and equivalents $367.5M at Dec 31, 2024; plus $80.7M net from public offering, funds operations into H2 2027.","Net loss $239.6M ($4.92 loss per share) for 2024, vs $308.5M loss in 2023; revenues $27.1M up from $15.8M.","Completed enrollment in third cohort of AMT-130 Phase I/II; initial safety update expected Q2 2025.","Restructuring and sale of Lexington facility reduced workforce by ~65%, cut cash burn ~$70M/year."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-001693","json":"https://secwatch.observer/filing/0001558370-25-001693.json","markdown":"https://secwatch.observer/filing/0001558370-25-001693.md","text":"https://secwatch.observer/filing/0001558370-25-001693.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590560/000155837025001693/0001558370-25-001693-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590560/000155837025001693/qure-20250227x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:49:40.364241+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}